Everything Everywhere All at Null

Five trials, four "negative" headlines, and why the nulls are the most useful thing you'll read before Monday rounds.

September 2026: The Munich Sessions: Statins Grow Old Gracefully, Endocarditis Gets the Short Course, and COPD Finally Gets Its Biologic

Five practice-shapers from a summer dominated by ESC and ERS, plus the pearls worth your Monday.

August 2026: The Summer Blockbuster Issue: Aspirin Wins, Kidneys Win, and an Old Antibiotic Makes a Comeback

July 2026: Cefazolin Wins. Colonoscopy Draws. Asundexian Changes the Game.

June 2026: Aspirin, Impella, and a Sepsis Tool That Shouldn't Work But Does

May 2026: The Tube Stops Here. Mortality Doesn't.

April 2026: Re-invigorated: COVID Fatigue Nixed By Fluvoxamine

...of all things.

March 2026: RSV Vaccines Helping Patients Live Their Best Life

At home.

February 2026: Olezarsen Crushes Pancreatitis Risk Like The Seahawks Did The Patriots

Game on.

January 2026: Fish Oil Helps Hemodialysis Patients? Word.

Definitely not faking the funk.

December 2025: Beta-Blockers For All Post-MI Patients? Not So Fast...

November 2025: Don't Call It A Comeback... For COVID Vaccines.

October 2025: We're going back in time...

Back to digitoxin, that is.

September 2025: Surgery? Where we're going, we don't need surgery..

August 2025: HFpEF Treatment Marches Forward

July 2025: Five Breakthroughs You Need to Know